AstraZeneca plans to invest USD 400m in the next four years in Colombia
AstraZeneca planea invertir USD 400m en los próximos cuatro años en Colombia
Intel ID : 425060
|
||||
| Intel ID | 425060 | ||
| Value | EUR 346,02m (Approx.) | ||
| Native Currency |
US Dollar (USD)
Exchange Rate:  |
||
|
Financial Data - Astrazeneca Colombia
(31 Dec 2024) |
Revenue: EUR 258,92m Net Debt: EUR 10,98m Exchange Rate: 
|
||
| Date |
|
||
| Country | |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Subsector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution (Primary) 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Subsectors (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 30.03.99 Other Healthcare Facilities & Services 30 Healthcare / 30.03 Healthcare Facilities & Services 15.08.99 Other Personal & Household Services 15 Consumer Products & Services / 15.08 Personal & Household Services |
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
15.08.99 Other Personal & Household Services 15 Consumer Products & Services / 15.08 Personal & Household Services 30.03.99 Other Healthcare Facilities & Services 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Ultimate Owner (Buyer)
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.